Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Master Protocol for Early Treatment and Post-Exposure Prophylaxis of COVID-19 Adaptive Platform Trial PROTECT-APT 1

NCT05954286 is registered in ClinicalTrials.gov with Henry M. Jackson Foundation for the Advancement of Military Medicine as lead sponsor.

NCT NCT05954286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05954286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Master Protocol for Early Treatment and Post-Exposure Prophylaxis of COVID-19 Adaptive Platform Trial PROTECT-APT 1
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase
Phase 2
Overall status
Completed
Start date
January 29, 2024
Completion date
April 24, 2025
Enrollment
92 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2